Challenges of New Party Drugs: New Psychoactive Substances
The emergence of New Psychoactive Substances (NPS) presents a significant challenge in the drug market, with legal sales online and phone inquiries to poison information centers indicating a concerning trend. The increased availability of NPS has led to deaths in clusters, highlighting the need for extended chemical screening to address the issue effectively.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
E N D
Presentation Transcript
The challenge of new party drugs New Psychoactive Substances SSAI/SFAI 2017
NPS - Legal drugs on the Internet Sales mostly online from different web shops Clear web: Legal internet shops (2013 EMDCCA indentified 651 web sales in Europe) Cryptomarket - DeepWeb: The Onion Router (TOR)/Dark web: SilkRoad, Cloud 9, Hydra and others Openings/closures 2014: 43 opened, 46 closed Sales are not for human consumption Research chemicals - Incense Spice Bad salts Plant nutrition Age limit On sale before classification Discrete delivery Ignorance Irresponsibility
New Psychoactive Substances Phone inquiries to Swedish Poisons Information Centre 2010- 2016 Ok nt Unknown/unclassified 1800 Arylalkylaminer 1600 Aminoindaner 1400 Piperidiner & pyrrolidiner Arylcyklohexylaminer 1200 Numbers Antal fall Opioider Opioids 1000 vriga (t.ex. difenidin) Others 800 Bensodiazepiner 600 Tryptamines 400 Syntetiska cannabinoider Katinoner 200 Fenetylaminer 0 2010 2011 2012 2013 2014 2015 2016 Year
Deaths come in clusters year 2009-2015 seven clusters identified (77 fatalities) N= 9 (11) Krypton 5-IT N= 13 AH-7921 N= 7 N= 15 (18) N= 5 (6) MT-45 PMMA N= 21 Acetylfentanyl N= 7 (12) Spice 2009 2010 2011 2012 2013 2014 2015
NPS - Conclusions Extent of real consumption is unknown In recent years a decline in classification of new drugs Most NPS sold today are already classified In recent years a decline in phone inquiries to poisons information centres Poisonings with NPS still a significant clinical problem 388 deaths between 2007-2015 in Sweden Extended chemical screening is necessary (get to know where, who and how) Deaths come in clusters Different fentanyls are on their way
